These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: a randomized trial. Stocker CF; Shekerdemian LS; Horton SB; Lee KJ; Eyres R; D'Udekem Y; Brizard CP J Thorac Cardiovasc Surg; 2011 Jul; 142(1):174-80. PubMed ID: 21420106 [TBL] [Abstract][Full Text] [Related]
63. Soluble Fas may be a proinflammatory marker after cardiopulmonary bypass in children. Joashi U; Tibby SM; Turner C; Mayer A; Austin C; Anderson D; Durward A; Murdoch IA J Thorac Cardiovasc Surg; 2002 Jan; 123(1):137-44. PubMed ID: 11782767 [TBL] [Abstract][Full Text] [Related]
64. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Gu YJ; Mariani MA; van Oeveren W; Grandjean JG; Boonstra PW Ann Thorac Surg; 1998 Feb; 65(2):420-4. PubMed ID: 9485239 [TBL] [Abstract][Full Text] [Related]
65. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass. Stammers AH; Christensen KA; Lynch J; Zavadil DP; Deptula JJ; Sydzyik RT J Extra Corpor Technol; 1999 Sep; 31(3):135-41. PubMed ID: 10847956 [TBL] [Abstract][Full Text] [Related]
66. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550 [TBL] [Abstract][Full Text] [Related]
67. Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study. Collart F; Caus T; Pomane C; Pellissier V; Chi Y; Montiès JR; Mesana T Artif Organs; 2000 Aug; 24(8):611-3. PubMed ID: 10971246 [TBL] [Abstract][Full Text] [Related]
68. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Steinberg BM; Grossi EA; Schwartz DS; McLoughlin DE; Aguinaga M; Bizekis C; Greenwald J; Flisser A; Spencer FC; Galloway AC Ann Thorac Surg; 1995 Sep; 60(3):525-9. PubMed ID: 7677475 [TBL] [Abstract][Full Text] [Related]
69. Anticoagulation during extracorporeal circulation under conditions of an ongoing systemic inflammatory response syndrome: effects of heparin. Feindt P; Litmathe J; Boeken U; Gams E Perfusion; 2005 Jan; 20(1):11-5. PubMed ID: 15751665 [TBL] [Abstract][Full Text] [Related]
70. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. Moen O; Fosse E; Bråten J; Andersson C; Høgåsen K; Mollnes TE; Venge P; Kierulf P Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352 [TBL] [Abstract][Full Text] [Related]
71. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. De Somer F; François K; van Oeveren W; Poelaert J; De Wolf D; Ebels T; Van Nooten G Eur J Cardiothorac Surg; 2000 Nov; 18(5):602-6. PubMed ID: 11053824 [TBL] [Abstract][Full Text] [Related]